Low Free T3 With a Normal TSH: The Thyroid Problem That Is Not a Thyroid Problem
2026-11-12Same post, two depths. Switch any time; the research version has the enzyme names, lab markers, and doses. Written from a research and education perspective: a model of what may be going on and what the published literature suggests would address it if the model is right, not medical advice or a treatment plan.
You are tired, cold, your hair is thinning, you cannot lose weight, and your thinking is slow. Your doctor checks TSH, it comes back normal, and the thyroid is declared fine. For a lot of people that is true. For a surprising number it is not, because TSH only tells you whether the gland is being asked to work. It does not tell you whether the hormone it makes is being switched on.
The thyroid in three sentences
The thyroid gland makes mostly T4, a storage form that does very little on its own. Your tissues convert T4 into T3, the active form, using enzymes called deiodinases, mostly in the liver, kidney, muscle, and brain. The gland can be perfect and the conversion can still fail, which leaves you with plenty of T4, a normal TSH, and not enough T3 where it counts.
There is also a third hormone, reverse T3. When the body wants to slow down, it converts T4 into reverse T3 instead of T3. Reverse T3 is inactive and blocks the receptor. It is the brake.
Why the body would do this on purpose
Low T3 with a normal TSH is called the non-thyroidal illness pattern, or low T3 syndrome. It was first described in hospital patients, where the body deliberately lowers T3 to conserve energy during serious illness. That is a sensible response to a crisis. The problem is that the same switch gets thrown by things that are not crises but feel like one to the body:
- Not eating enough. Calorie restriction, skipped meals, and very low-carbohydrate eating lower T3 within days. This is the most common cause in people trying to lose weight and getting more tired instead.
- Inflammation. The signal molecules of inflammation (especially IL-6) suppress the enzyme that makes T3 and turn on the one that makes reverse T3.
- Stress hormone. Sustained high cortisol does the same.
- Low iron. The enzyme that builds thyroid hormone contains iron, and iron deficiency lowers T3 conversion. See the ferritin post here.
- Low selenium. The deiodinase enzymes are built around selenium. Without it, T4 piles up and T3 does not get made.
- Low zinc. Needed for both the conversion and the receptor.
- Gut inflammation and dysbiosis. About 20 percent of T4 to T3 conversion happens in the gut, carried out by bacterial enzymes. See the SIBO post here.
- Certain drugs. Beta-blockers, steroids, amiodarone, and some others slow conversion. The medications table here lists them.
- A gene variant. A common variant in the DIO2 gene (the one that makes the brain's own T3) is linked to worse wellbeing on T4-only treatment and may matter in people who feel bad despite normal labs. The thyroid here report covers it.
What it feels like
Fatigue that sleep does not fix, feeling cold, slow pulse, puffy face or ankles in the morning, dry skin, thinning outer eyebrows, constipation, low mood, slow thinking, weight that does not move, high cholesterol that appeared without a diet change, and, in people with POTS, a worse morning.
The labs that show it
A TSH alone will miss it. The pattern is:
- TSH normal
- Free T4 normal, often upper half
- Free T3 low or in the bottom quarter of the range
- Reverse T3 high or upper range
- The ratio of free T3 to reverse T3 low
Add thyroid antibodies (TPO and thyroglobulin) once, because autoimmune thyroid disease can hide under a normal TSH for years and changes the plan. Add ferritin, selenium, zinc, and CRP, because they are the most common fixable reasons the conversion fails. The lab guide here has the functional ranges.
If the model is right, what the research points to
- Eat enough, including carbohydrate. T3 conversion needs insulin and enough calories. If you have been under-eating or on a very low-carb plan and feel worse, that is the first thing to test. Three meals, protein at each, and some carbohydrate from the substrate separation plan here is usually enough.
- Fix the iron. Ferritin over 50 (and higher if restless legs are present) before expecting the thyroid numbers to move.
- Selenium. Two Brazil nuts a day supply about 100 to 200 mcg, but the amount varies wildly by soil, so a supplement of 100 to 200 mcg selenomethionine is more reliable. Do not exceed 200 mcg daily from all sources. Selenium also lowers TPO antibodies in people who have them.
- Zinc. 15 to 25 mg daily with copper (zinc without copper causes copper deficiency, which looks like iron deficiency). Jarrow Zinc Balance is the form used on this site (my favorite products).
- Lower the inflammation signal. Whatever is driving IL-6 in you: gut dysbiosis, mast cell activation, poor sleep, excess visceral fat, a chronic infection. The posts on this site are mostly about finding that driver.
- Lower the cortisol signal. Not a supplement; a schedule. Sleep at consistent times, morning light, no training on empty, and the breathing practice from the pots post here. High-dose stimulants and chronic under-sleeping keep the brake on.
- Iodine is not the fix for most people. Iodine deficiency is real in some places, but adding iodine to someone with Hashimoto's can worsen it. Test urinary iodine before supplementing, and keep it to food amounts (seaweed, fish, eggs, dairy) unless a clinician directs otherwise.
- The T3 medication question belongs to your clinician. Adding liothyronine (T3) or switching to a combination has helped some people in trials, especially those with the DIO2 variant, and not others. It is a prescription decision with real risks for the heart and bones if overdone. What you can bring to that conversation is the full panel and the list of conversion blockers you have already fixed.
When it is actually the thyroid
If TSH is above 2.5 with symptoms, antibodies are positive, or free T4 is low, that is a gland problem, not a conversion problem, and it needs a clinician. The point of this page is that a normal TSH is where the question starts, not where it ends.
Educational content written from a research perspective, not medical advice. I am a PhD scientist, not a physician, and I do not diagnose, treat, cure, or prevent disease. Thyroid medication decisions, including any use of T3, are made by a prescribing clinician. Take anything you want to try to your own healthcare provider.
Why TSH is necessary but not sufficient
TSH reflects pituitary sensing of thyroid hormone, and the pituitary is unusual: it expresses type 2 deiodinase (DIO2) abundantly and generates most of its own T3 locally from T4. Pituitary T3 status can therefore be normal, and TSH normal, while peripheral T3 generation in liver, kidney, and muscle (type 1 deiodinase, DIO1) is reduced. The pituitary is also relatively protected from the cytokine and cortisol signals that suppress DIO1 and induce type 3 deiodinase (DIO3) in peripheral tissues. The result is the non-thyroidal illness (NTI) pattern: low or low-normal free T3, normal or high-normal free T4, raised reverse T3, and a normal TSH.
NTI is well described in critical illness, where it is adaptive and should not be treated. The same biochemistry appears, at lower amplitude, in caloric restriction, chronic inflammation, chronic stress, iron and selenium insufficiency, and some medication exposures, in ambulatory people who feel hypothyroid with a normal TSH. Whether that lower-amplitude pattern is adaptive, maladaptive, or both depends on the driver, which is the reason to identify the driver rather than argue about the number.
Deiodinase biology in one table
| Enzyme | Tissue | Reaction | Cofactor | Regulated by |
|---|---|---|---|---|
| DIO1 | Liver, kidney, thyroid | T4 to T3 (outer ring); rT3 clearance | Selenocysteine | Down by IL-6, TNF, cortisol, fasting, low insulin; up by T3 |
| DIO2 | Pituitary, brain, brown fat, muscle, thyroid | T4 to T3 locally | Selenocysteine | Down by T4 (ubiquitination); Thr92Ala variant reduces activity in some tissues |
| DIO3 | Placenta, brain, skin; induced in illness | T4 to rT3, T3 to T2 (inactivation) | Selenocysteine | Up by hypoxia, inflammation, cortisol, HIF-1 |
All three are selenoproteins; selenium deficiency lowers DIO1 activity, raises the T4 to T3 ratio, and in iodine-replete populations modestly lowers T3. Thyroid peroxidase, which synthesizes T4, is a heme enzyme and iron-dependent. Zinc is required for DIO activity and for thyroid receptor DNA binding.
Drivers of the ambulatory low T3 pattern
- Energy deficit. Caloric restriction lowers serum T3 within 2 to 3 days via reduced hepatic DIO1, reduced leptin signaling to the hypothalamus, and reduced insulin. Very low carbohydrate diets lower T3 independent of calories in several studies, likely through the insulin pathway. The effect reverses with refeeding, particularly carbohydrate.
- Inflammation. IL-6 lowers DIO1 and induces DIO3; serum IL-6 correlates inversely with T3 in NTI. Chronic low-grade inflammation from visceral adiposity, dysbiosis, periodontal disease, mast cell activation, or persistent infection reproduces the pattern at lower amplitude.
- Glucocorticoids. Cortisol and exogenous steroids suppress TSH pulsatility and DIO1 and raise rT3. Chronic sleep restriction and sustained psychological stress act through the same axis.
- Iron deficiency. Reduces TPO activity and T4 synthesis, reduces DIO1, blunts the thyroid response to iodine, and impairs levothyroxine efficacy. Ferritin targets are in the ferritin post here.
- Selenium and zinc. As above. Selenium supplementation (100 to 200 mcg selenomethionine) lowers TPO antibody titers in autoimmune thyroiditis across several trials and improves the T4 to T3 ratio in deficient subjects.
- Gut. Intestinal sulfatases and beta-glucuronidases from the microbiota deconjugate T3 sulfate and glucuronide, recovering roughly 20 percent of circulating T3; dysbiosis, SIBO, and antibiotic exposure reduce this. Intestinal inflammation raises systemic IL-6. See the SIBO post here.
- Medications. Glucocorticoids, propranolol (high dose), amiodarone, iodinated contrast, lithium, and some antiepileptics lower DIO1 or raise rT3; biotin interferes with immunoassays and should be stopped 48 to 72 hours before testing. See the medications table here.
- DIO2 Thr92Ala (rs225014). Carriers show lower DIO2 activity in some tissues, altered brain T3 in animal models, and in several studies worse psychological wellbeing on levothyroxine monotherapy with a preferential response to combination therapy. Findings are inconsistent across cohorts; the variant is best treated as a reason to look harder, not as a diagnosis. The thyroid here report covers DIO1, DIO2, TSHR, TPO, SELENOP, and transport genes.
The panel and the functional read
| Marker | Conventional range (typical) | Functional position used here | Pattern in ambulatory low T3 |
|---|---|---|---|
| TSH | 0.4 to 4.5 mIU/L | 0.5 to 2.0 in the absence of disease; over 2.5 with symptoms warrants antibodies and repeat | Normal |
| Free T4 | 0.8 to 1.8 ng/dL | Mid-range | Normal to upper half |
| Free T3 | 2.3 to 4.2 pg/mL | Upper half (3.2 to 4.2) | Bottom quartile |
| Reverse T3 | 9 to 24 ng/dL | Under 15 | Upper range or above |
| Free T3 to rT3 ratio | Over 0.2 (pg/mL to ng/dL), equivalently over 20 in ng/dL units | Low | |
| TPO and Tg antibodies | Negative | Negative; selenium and gluten status if positive | Variable |
| Ferritin, selenium (plasma or whole blood), zinc, CRP, fasting insulin | See the lab guide here | Explain most cases |
Pre-analytics: draw fasting in the morning before any thyroid dose; stop biotin 72 hours; avoid testing during acute illness, within 6 weeks of iodinated contrast, or within 2 weeks of a major caloric change. Free T3 by immunoassay is less reliable than by equilibrium dialysis with LC-MS/MS, which is available through most national reference laboratories when the question matters.
What the literature suggests addresses each node
- Restore energy and carbohydrate availability. Refeeding reverses restriction-induced low T3 within days. In someone under-eating or on sustained very low carbohydrate intake with the pattern, a trial of adequate calories and 100 to 150 g daily carbohydrate, kept within substrate separation here, is the least invasive test of the model.
- Iron, selenium, zinc. Ferritin to over 50 ng/mL (with saturation and CRP); selenium 100 to 200 mcg daily as selenomethionine, not exceeding 200 mcg from all sources and not exceeding 400 mcg ever; zinc 15 to 25 mg with 1 to 2 mg copper. Selenium status can be verified by plasma selenium or selenoprotein P where available.
- Reduce the IL-6 signal at its source. The source differs by person: gut (stool calprotectin, breath test, dietary trials), mast cells (mediator panel, low-histamine trial), adiposity and insulin resistance (fasting insulin, substrate separation), sleep (polysomnography where indicated), dental and chronic infection. Omega-3 index to 8 percent and vitamin D to 40 to 60 ng/mL modestly lower inflammatory tone in trials.
- Reduce the glucocorticoid signal. Consistent sleep timing, morning light, avoidance of training in a fasted state, and the slow-breathing practice described in the pots post here all reduce cortisol in controlled studies; none is a supplement. Stimulant dose and timing should be reviewed with the prescriber.
- Iodine with caution. Supplemental iodine above about 150 to 250 mcg daily can precipitate or worsen autoimmune thyroiditis; spot urinary iodine under 100 mcg/L indicates insufficiency worth correcting through food or modest supplementation. Kelp products deliver unpredictable doses.
- Combination therapy is a prescribing decision. Meta-analyses of T4 plus T3 versus T4 alone show no consistent superiority overall, with signals of benefit in the subgroup with persistent symptoms and possibly in DIO2 Thr92Ala carriers; the 2021 ATA, BTA, and ETA consensus statement allows a trial of combination therapy in selected patients. Sustained-release T3 and T3-only protocols lack adequate trial support, and supraphysiologic T3 carries atrial fibrillation and bone loss risk. The useful contribution from the research side is the full panel, the fixed cofactors, and the documented dietary and inflammatory state, which make the prescribing decision an informed one.
Retesting
Six to eight weeks after any change in iron, selenium, zinc, calories, or medication; full panel each time, same laboratory, same time of day. Expect free T3 to move before symptoms fully resolve and rT3 to fall as the inflammatory or caloric driver is removed.
Educational and research content, not medical advice. The author holds a PhD in cellular and molecular nutrition, is not a licensed physician, and does not diagnose, treat, cure, or prevent disease. Thyroid hormone prescribing, including any trial of T3, is a clinical decision made by the treating physician.
